| Property | Value |
|---|
|
?:abstract
|
-
Researchers launched the American Society of Hematology Research Collaborative COVID-19 Registry for Hematology in April to gather real-time data on patients with hematologic malignancies who develop COVID-19. Now, an analysis of the data reveals that 33% of patients with blood cancers who were hospitalized for COVID-19 died. Risk factors included older age, forgoing intensive treatment, and poor prognosis before infection.
|
|
is
?:annotates
of
|
|
|
?:doi
|
|
|
?:doi
|
-
10.1158/2159-8290.cd-nb2020-112
|
|
?:journal
|
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Survival Factors ID\'d for Patients with Blood Cancer + COVID-19.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}